valerates has been researched along with Cardiomegaly in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Chen, YE; Cheng, S; Cui, X; Dong, E; Gao, J; Garcia-Barrio, MT; Ji, L; Jiang, H; Li, C; Liu, C; Meng, X; Pan, B; Shan, W; Song, M; Sun, H; Wang, DW; Wei, H; Yi, Y; Zhan, R; Zhao, M; Zheng, L | 1 |
1 other study(ies) available for valerates and Cardiomegaly
| Article | Year |
|---|---|
Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy.
Topics: Amino Acids, Neutral; Animals; Cardiomegaly; Fatty Acids; Gastrointestinal Microbiome; Humans; Mice; Prospective Studies; Valerates | 2022 |